Erratum to “Incorporation of alemtuzumab into frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study”

Documenti analoghi

• Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase
  di: Fadi G. Haddad, et al.
  Pubblicazione: (2024)
• Outcome of second‐line therapy in adult B‐cell acute lymphoblastic leukemia
  di: Hagop Kantarjian, et al.
  Pubblicazione: (2026)
• The evolving therapeutic revolution in adult acute lymphoblastic leukemia
  di: Hagop Kantarjian, et al.
  Pubblicazione: (2025)
• Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions
  di: Hagop M. Kantarjian, et al.
  Pubblicazione: (2024)
• Reduced‐dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B‐cell acute lymphoblastic leukemia
  di: Jing Lu, et al.
  Pubblicazione: (2024)